Current advances in pain regimens for percutaneous nephrolithotomy

A comprehensive review

Authors

  • Tomas Paneque LSU Health Shreveport Urology
  • John Richey
  • Ahmad Abdelrazek
  • Kevin Morgan
  • Joseph Fitz-Gerald
  • Seth Swinney
  • Zachary M. Connelly
  • Nazih Khater

DOI:

https://doi.org/10.5489/cuaj.8333

Keywords:

Percutaneous nephrolithotomy (PCNL), postoperative pain, treatment strategies, reducing morbidity and mortality of PCNL

Abstract

INTRODUCTION: Percutaneous nephrolithotomy (PCNL) causes pain and discomfort after surgery. The primary causes of immediate postoperative pain after PCNL are visceral pain from the ureters and kidneys, and body surface discomfort from incisions. Acute, untreated pain has the potential to develop into chronic pain, which remains a considerable burden for the rehabilitation of patients. The goal of this review was to describe the current options for treating pain post-PCNL.

METHODS: We conducted a literature review of all published manuscripts on pain protocols for patients undergoing PCNL and related topics; 50 published manuscripts were identified and reviewed.

RESULTS: PCNL morbidity must be reduced by an appropriate management of postoperative pain. Opioids, multimodal therapy, tubeless PCNL, reduced size of nephrostomy tube, and regional anesthesia are currently available for reducing postoperative pain.

CONCLUSIONS: Implementing successful treatment strategies for postoperative pain after PCNL is key in reducing the morbidity and mortality of PCNL.

Downloads

Download data is not yet available.

Downloads

Published

2023-08-03

How to Cite

Tomas Paneque, John Richey, Ahmad Abdelrazek, Kevin Morgan, Joseph Fitz-Gerald, Seth Swinney, Zachary M. Connelly, & Nazih Khater. (2023). Current advances in pain regimens for percutaneous nephrolithotomy: A comprehensive review. Canadian Urological Association Journal, 17(11), E388–94. https://doi.org/10.5489/cuaj.8333

Issue

Vol. 17 No. 11 (2023): CUAJ November

Section

Review

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.